Analyst firms · Morgan Stanley · IRON

Morgan Stanley IRON price target and rating history

Disc Medicine Inc. (IRON) · Health Care

Morgan Stanley rates Disc Medicine Inc. (IRON) Overweight with a $85 price target, as of its latest action on Jul 3, 2025. It has published 4 rating actions on IRON since April 2023, including 1 upgrade and 1 downgrade.

Current rating
Overweight
Price target
$85
Median target, all firms
Too few
Actions on IRON
4

Morgan Stanley price target on IRON

$85$61$37202420252026
Morgan Stanley price target on IRON, each point a stated target, April 2023 to July 2025.

Every Morgan Stanley rating on IRON

Questions about Morgan Stanley and IRON

What is Morgan Stanley's price target for IRON?
Morgan Stanley's latest stated price target for Disc Medicine Inc. (IRON) is $85, from its action on Jul 3, 2025.
What is Morgan Stanley's rating on IRON?
Morgan Stanley rates IRON Overweight, a bullish rating, as of Jul 3, 2025.
When did Morgan Stanley last change its view on IRON?
On Jul 3, 2025, Morgan Stanley resumes coverage at Overweight, price target $85.

More IRON rating histories

All Morgan Stanley ratingsIRON news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.